Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial

BACKGROUND: Nanoparticle albumin-bound (nab)-paclitaxel has better efficacy, safety profiles, and no need to use prophylactic steroids compared with solvent-based paclitaxel. We performed a single arm, phase II study to evaluate the efficacy and safety of weekly nab-paclitaxel and gemcitabine combin...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cancer
Auteurs principaux: Zhao, Yannan, Lv, Fangfang, Chen, She, Wang, Zhonghua, Zhang, Jian, Zhang, Sheng, Cao, Jun, Wang, Leiping, Cao, Enying, Wang, Biyun, Hu, Xichun
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2018
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6196471/
https://ncbi.nlm.nih.gov/pubmed/30348118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4936-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires